CELG-RI
Bristol-Myers Squibb Company Ce
NYSE · Healthcare · Drug Manufacturers - General · US
$0.14
−6.69%Next report
Analyst consensus
- Next report date
- Oct 29, 2026
- EPS estimate
- $1.72
- Revenue estimate
- $12.6B
Latest reported
- Last report date
- Jul 30, 2026
- EPS actual
- $2.04
- EPS estimate
- $1.60
- Revenue actual
- $13.0B
- Revenue estimate
- $11.7B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 2
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -11.7%
- Revenue beats (12Q)
- 5
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 29, 2026